Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-05-05-01 Angiotensin-converting enzyme inhibitors (ACE inhibitors)
| Perindopril erbumine |
|
Formulary
|
Tablets 2mg, 4mg, 8mg
Perindopril ARGININE is considered ‘Not suitable for prescribing’. |
 NHSE: Items which should not routinely be prescribed in primary care: policy guidance |
|
| Enalapril |
|
Formulary
|
Tablets 2.5mg, 5mg, 10mg, 20mg
|
|
NG133: Hypertension in pregnancy: diagnosis and management |
|
Restricted to use in post-natal women, in line with NG133.Links
Enoxaparin for Treatment of Venous Thromboembolism **FOR USE IN THE BLACKPOOL REGION ONLY** - Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY* - LSC Hypertension in Adults: Diagnosis and Management
- LSC Patient Pathway for Commencing Inclisiran
- LSC Statin Intolerance Pathway
- LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- MHRA: ACE-inhibitors: Be aware of the distinction between bradykinin- and histamine-mediated angioedema, as treatment strategies differ significantly
- NG133: Hypertension in pregnancy: diagnosis and management
- NHSE: Items which should not routinely be prescribed in primary care: policy guidance
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG185: Acute Coronary Syndromes
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG196: Atrial fibrillation: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA731:Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
- Policy and procedure for prophylaxis against, and treatment of, VTE in adult patients **FOR USE IN THE CENTRAL LANCS REGION ONLY**
- Prevention of VTE in Medical Surgical Patients (16 years +) and those requiring lower limb plaster casts/immobilisations **FOR USE IN THE BLACKPOOL REGION ONLY**
- Renal: Enhanced Supportive Kidney Care Guideline